Go to The Journal of Clinical Investigation
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
  • Physician-Scientist Development
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Immunology
    • Metabolism
    • Nephrology
    • Oncology
    • Pulmonology
    • All ...
  • Videos
  • Collections
    • In-Press Preview
    • Resource and Technical Advances
    • Clinical Research and Public Health
    • Research Letters
    • Editorials
    • Perspectives
    • Physician-Scientist Development
    • Reviews
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • In-Press Preview
  • Resource and Technical Advances
  • Clinical Research and Public Health
  • Research Letters
  • Editorials
  • Perspectives
  • Physician-Scientist Development
  • Reviews
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
Mst1-mediated phosphorylation of Bcl-xL is required for myocardial reperfusion injury
Michinari Nakamura, Peiyong Zhai, Dominic P. Del Re, Yasuhiro Maejima, Junichi Sadoshima
Michinari Nakamura, Peiyong Zhai, Dominic P. Del Re, Yasuhiro Maejima, Junichi Sadoshima
View: Text | PDF
Research Article Cardiology Cell biology

Mst1-mediated phosphorylation of Bcl-xL is required for myocardial reperfusion injury

  • Text
  • PDF
Abstract

Mst1 is a central Ser-Thr kinase in the Hippo pathway, which promotes apoptosis and inhibits cell proliferation. We have shown previously that, in cardiomyocytes, oxidative stress activates Mst1 at mitochondria, where Mst1 phosphorylates Bcl-xL at Ser14, inducing dissociation of Bcl-xL from Bax and thereby promoting apoptosis. However, the functional significance of Ser14 phosphorylation of endogenous Bcl-xL in vivo remains elusive. We generated knockin (KI) mice in which Ser14 of Bcl-xL is replaced with Ala. KI mice were born at the expected Mendelian ratio, and adult KI mice exhibited normal cardiac morphology and function at baseline. However, KI mice were protected from myocardial ischemia/reperfusion (I/R) injury and exhibited reduced cardiomyocyte apoptosis. Although suppression of endogenous Mst1 also reduced I/R injury, there was no additive protective effect when Mst1 was inhibited in KI mice. The development of dilated cardiomyopathy induced by cardiac-specific overexpression of Mst1 was also ameliorated in KI mice. Lats2 and YAP, two other key components of the Hippo pathway, were not affected in KI mice. These results suggest that Ser14 phosphorylation of Bcl-xL plays an essential role in mediating both cardiomyocyte apoptosis and myocardial injury by acting as a key downstream mediator of Mst1 independently of the canonical Hippo pathway.

Authors

Michinari Nakamura, Peiyong Zhai, Dominic P. Del Re, Yasuhiro Maejima, Junichi Sadoshima

×

Figure 2

Bcl-xL S14A knockin mice are protected against ischemia/reperfusion injury.

Options: View larger image (or click on image) Download as PowerPoint
Bcl-xL S14A knockin mice are protected against ischemia/reperfusion inju...
(A) Immunoblots showing expression of p-Bcl-xL (S14), total Bcl-xL, p-Mst1 (T183), total Mst1, and cleaved caspase-3 and -9 in the hearts of mice with sham operation or ischemia/reperfusion (I/R). (B) Immunoblots showing active Bax (6A7). The data are representative of 3 independent experiments. (C) Quantification of activated Bax (n = 3). (D) Immunoblots showing cytochrome c release in the hearts of WT and KI mice subjected to sham or I/R operation. The data are representative of 3 independent experiments. (E) Immunoblots showing p-Lats2 and p-YAP. (F) Quantification of the p-Lats2/Lats2 and p-YAP/YAP ratios (n = 4–6). The Hippo signaling pathway was not altered in KI mice compared with that in WT mice in response to sham or I/R operation. (G) Representative images of infarct size (white) and area at risk (AAR) (not blue) in the heart. Scale bar: 1 mm. Quantification of percentage AAR (AAR/left ventricle) and percentage myocardial infarction (MI; infarct area/AAR) (n = 6–7). (H) TUNEL-stained sections (ischemic area) of hearts from WT and KI mice following I/R and quantification of the percentage TUNEL-positive nuclei (n = 5). Scale bar: 50 μm (top); 10 μm (bottom). Data are mean ± SEM. *P < 0.01, **P < 0.001, 2-tailed unpaired Student’s t test for 2 groups or 1-way ANOVA followed by the Newman-Keuls post-hoc analysis for 3 groups or more.

Copyright © 2026 American Society for Clinical Investigation
ISSN 2379-3708

Sign up for email alerts